半合成的环类固醇酸乙和酸-丁氧胺乙衍生物具有酸性活性
Márton B Háznagy1, Gábor Girst1, Máté Vágvölgyi1
1Institute of Pharmacognosy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.
Journal of natural products
|October 17, 2024
概括
研究人员确定了一种新的潜在药物候选物,即埃克迪斯特洛伊德44 (ecdysteroid 44),用于治疗查加斯病. 这种化合物对寄生虫Trypanosoma cruzi表现出强大和选择性的活性,为目前有限的治疗方法提供了一个有希望的替代方案.
科学领域:
- 药用化学 医学化学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 由Trypanosoma cruzi引起的查加斯病是一种被忽视的热带疾病,治疗选择有限.
- 目前的药物如尼达和尼福蒂莫克斯对于疾病的慢性阶段来说并不理想.
- 埃克迪松衍生物已经显示出干扰T. cruzi生命周期的潜力.
研究的目的:
- 为了识别针对Trypanosoma cruzi.的选择性三酸性生态类固醇.
- 为了生物学地描述和优化半合成的ecdysteroids.
- 为了发现查加斯病的新型候选药物.
主要方法:
- 对47种ecdysteroids进行查,以检测它们的tripanocidal活性.
- 确定关键的药解剂 (6-tert-butyl oxime 乙烯和 cinnamic ester).
- 合成和评估新型半合成体 (化合物44-47).
- 细胞感染检测测试验以评估阿马斯蒂哥特复制抑制.
- 对T. cruzi和宿主巨细胞的细胞毒性评估.
主要成果:
- 确定了两个中度的三酸性药.
- 化合物44是一种半合成的ecdysteroid,表现出强烈和选择性的tripanocidal活性 (IC50<2μM).
- 乙类固醇44有效抑制了阿马斯蒂哥特的复制 (IC50 = 2.7 ± 0.1 μM),并且比尼达更有选择性.
- 与宿主巨细胞相比,化合物44对T. cruzi的细胞毒性超过5倍.
结论:
- 乙类固醇肉酸乙44是一种新型的结构,具有强大和选择性的tripanocidal活性.
- 这种化合物代表了进一步开发查加斯病治疗的有希望的候选者.
- 为了其潜在的治疗应用,需要进一步描述ecdysteroid 44的特性.
相关概念视频
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
149
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
149
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
534
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
534
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.1K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.1K